NYSE · Healthcare Plans · USD
Oscar Health, Inc. (OSCR) Stock Analysis
Oscar Health, Inc. (OSCR) is a Healthcare Plans stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
OSCR Key Statistics
As of Sep 4, 2026Trading
- Open
- $32.19
- Previous Close
- $32.24
- Day's Range
- 31.53–32.49
- 52-Week Range
- 10.69–33.55
- Volume
- 3.69M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 2.37
Valuation
- Market Cap
- $9.95B
- P/E Ratio
- 24.81
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 17.14
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.65
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 1.30
Financials (FY)
- Revenue (FY)
- $11.70B+27.50%
- Net Income (FY)
- −$443.15M−1842.49%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 3.60%
- Shares Outstanding
- 273.47M
- 1-Year Return
- +75.46%
Dividend and dates
- Earnings Date
- November 9, 2026
- Avg Volume
- 5.77M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
OSCR Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +124.43% |
| 2025 | +6.92% |
| 2024 | +46.89% |
| 2023 | +271.95% |
| 2022 | −68.66% |
| 2021 (partial year) | −77.44% |
As of September 4, 2026.
OSCR Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $11.70B | −$443.15M | −3.8% |
| 2024 | $9.18B | $25.43M | 0.3% |
| 2023 | $5.86B | −$270.73M | −4.6% |
| 2022 | $4.13B | −$606.28M | −14.7% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $11.70B | — | — | −$443.15M | −3.8% |
| 2024 | $9.18B | — | — | $25.43M | 0.3% |
| 2023 | $5.86B | — | — | −$270.73M | −4.6% |
| 2022 | $4.13B | — | — | −$606.28M | −14.7% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
OSCR Valuation vs Healthcare Plans Median
Median of 11 stocks| Metric | OSCR | Healthcare Plans median | vs median |
|---|---|---|---|
| P/E | 24.81 | 25.66 | 3% below |
| P/S ratio | 0.65 | 0.44 | 48% above |
| Profit margin | 3.60% | 1.18% | 2.4 pts above |
Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Oscar Health (NYSE:OSCR) Displays High Growth Momentum With a Defined Breakout Setup
ChartMillOscar Health Membership Surges but Profitability Remains Key
YahooOscar Health Skyrockets 109% YTD: Time to Bet on the Stock Now?
YahooIs Oscar Health (OSCR) Still Below Fair Value After 3.6x Gains?
YahooIs Oscar Health (OSCR) Fully Priced Following Raised 2026 Guidance?
YahooHow Strong First-Half Results And Raised Guidance At Oscar Health (OSCR) Have Changed Its Investment Story
Yahoo
All 20 articles ↓Show fewer ↑
Oscar Health (OSCR) Price Target Increased by 22.62% to 29.50
FintelHIMS Stock Climbs Overnight: Oscar Health CEO Courts Hims For New Drug Marketplace
YahooIs Oscar Health (OSCR) Undervalued After Its Earnings Beat And Guidance Raise?
YahooCan Oscar Health (OSCR) Still Look Cheap After Strong Q2?
YahooOscar Health’s Q2 Earnings Call: Our Top 5 Analyst Questions
YahooWhy Did Oscar Health (OSCR) Fall After Record Profit and a Guidance Hike?
YahooQ2 Earnings Roundup: Oscar Health (NYSE:OSCR) And The Rest Of The Health Insurance Providers Segment
YahooWells Fargo Maintains Equal-Weight on Oscar Health, Raises Price Target to $27
BenzingaOscar Health (NYSE:OSCR) Displays Accelerating Growth and Improving Fundamentals
ChartMillOSCR Q2 Deep Dive: Individual Market Growth and AI Investments Shape Outlook
YahooOscar Health Q2 Earnings Call Highlights
YahooUBS Maintains Neutral on Oscar Health, Raises Price Target to $26
BenzingaBarclays Maintains Overweight on Oscar Health, Raises Price Target to $39
BenzingaOscar Health (OSCR) Q2 2026 Earnings Call Transcript
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Healthcare Plans Stocks
UnitedHealth Group Incorporated
$356.47B
CVSCVS Health Corporation
$123.73B
ELVElevance Health, Inc.
$88.37B
CIThe Cigna Group
$74.65B
HUMHumana Inc.
$48.22B
CNCCentene Corporation
$33.12B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
NVSNovartis AG
$304.10B











